ConductScience.org, home

Paper42700331

Recent advancements in NRF2-regulated ferroptosis modulation for targeted cancer therapy.

Ulker OC and 5 others. Mol Biol Rep, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Recent advancements in NRF2-regulated ferroptosis modulation for targeted cancer therapy. Papers, record 42700331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42700331

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent advancements in NRF2-regulated ferroptosis modulation for targeted cancer therapy.
PubMed
Journal
Mol Biol Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-05
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FerroptosisMajor topic
NF-E2-Related Factor 2Major topic
NeoplasmsMajor topic
Humans
Signal Transduction
Animals
Lipid Peroxidation
Oxidative Stress
Iron
Molecular Targeted Therapy
Drug Resistance, Neoplasm

Source PubMed

Download CSV of topics

References152

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127552339Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors.ACS Chem Biol2016https://conductscience.org/library/papers/27552339PubMed
240041932Randomized Phase II Clinical Trial of Sulforaphane in Former Smokers at High Risk for Lung Cancer.Cancer Prev Res (Phila)2025https://conductscience.org/library/papers/40041932PubMed
337217183Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study.Blood2023https://conductscience.org/library/papers/37217183PubMed
420512470Effect of stable inhibition of NRF2 on doxorubicin sensitivity in human ovarian carcinoma OV90 cells.Arch Pharm Res2010https://conductscience.org/library/papers/20512470PubMed
531595562Recent Progress in Ferroptosis Inducers for Cancer Therapy.Adv Mater2019https://conductscience.org/library/papers/31595562PubMed
629274359Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis.Cancer Lett2018https://conductscience.org/library/papers/29274359PubMed
736909174Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis.Front Pharmacol2023https://conductscience.org/library/papers/36909174PubMed
834843044A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies.Target Oncol2022https://conductscience.org/library/papers/34843044PubMed
928665143Suppression of Lipogenesis via Reactive Oxygen Species-AMPK Signaling for Treating Malignant and Proliferative Diseases.Antioxid Redox Signal2018https://conductscience.org/library/papers/28665143PubMed
1041461245Integrating multi-omics and artificial intelligence fuels advanced target identification and drug discovery.Biotechnol Adv2026https://conductscience.org/library/papers/41461245PubMed
1136453238Triptolide promotes ferroptosis by suppressing Nrf2 to overcome leukemia cell resistance to doxorubicin.Mol Med Rep2023https://conductscience.org/library/papers/36453238PubMed
1238561058Esculin induces endoplasmic reticulum stress and drives apoptosis and ferroptosis in colorectal cancer via PERK regulating eIF2α/CHOP and Nrf2/HO-1 cascades.J Ethnopharmacol2024https://conductscience.org/library/papers/38561058PubMed
1340911942RNF217-KEAP1-NRF2 feedback loop confers therapeutic resistance by inhibiting ferroptosis in esophageal squamous cell carcinoma.Drug Resist Updat2025https://conductscience.org/library/papers/40911942PubMed
1430339884Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.Free Radic Biol Med2018https://conductscience.org/library/papers/30339884PubMed
1538663476Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway.Exp Cell Res2024https://conductscience.org/library/papers/38663476PubMed
1627002157Translation Regulation of the Glutamyl-prolyl-tRNA Synthetase Gene EPRS through Bypass of Upstream Open Reading Frames with Noncanonical Initiation Codons.J Biol Chem2016https://conductscience.org/library/papers/27002157PubMed
1737237486PI3K/AKT/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications.Biology (Basel)2023https://conductscience.org/library/papers/37237486PubMed
1829717933The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis.Physiol Rev2018https://conductscience.org/library/papers/29717933PubMed
1936994475Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response.Mol Cells2023https://conductscience.org/library/papers/36994475PubMed
2026403645Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.Hepatology2016https://conductscience.org/library/papers/26403645PubMed

See all 152 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NFE2L24780PubTator's text mininghttps://conductscience.org/library/genes/4780

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42700331

GET https://conductscience.org/api/papers/v1/42700331/references?page=2